SIGN UP
Back to Resources
Date: March 19, 2020
Category: COVID-19 Response
    Share
    on Social:
Print this
page:

SAMHSA: FAQ on the provision of methadone and buprenorphine for the treatment of OUD in the COVID-19 Emergency

The Substance Abuse and Mental Health Services Administration (SAMHSA) has compiled an FAQ on prescribing MOUD during the COVID-19 pandemic.

View Resource

Related Grants & Resources

Webinar: State Policy Landscape to Address the Opioid and Overdose Crisis in 2024
March 14, 2024
Addiction Policy Forum

COVID-19 Vaccine Navigators for the Substance Use Disorder Population

Mar. 2021 - Aug. 2021
Webinar: Federal Policy and Regulatory Opportunities to Address the Opioid and Overdose Crisis in 2024
January 26, 2024